Translating Neurological Stem Cell Research into Therapies for Today’s Patients

Speaker: Thomas Hartung, MD, PhD, Consulting VP of Scientific Affairs at AxoSim and Professor and Chair, Johns Hopkins University

Neurological impairments are usually irreversible because of limited regeneration in the central nervous system. The regenerative capacity of stem cells makes them an attractive candidate for transplantation therapies, with many stem cells showing promise in basic research and preclinical trials.

Learn about how advances in iPSC-derived organoid models recapitulate the “real” brain environment for CNS precision medicine.